Stockreport

REGENXBIO's Late-Stage Pipeline Momentum Strengthens After Q3 Earnings Beat [Seeking Alpha]

REGENXBIO Inc.  (RGNX) 
Last regenxbio inc. earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.regenxbio.com
PDF RGNX's pipeline advances include a key PDUFA date for clemidsogene lanparvovec in Hunter syndrome and promising developments in Duchenne muscular dystrophy and ophthalm [Read more]